Latest information on COVID-19


The Malhotra Laboratory in the Department of Radiation Oncology- Division of Cancer Biology at Stanford University is focused on the design and discovery of synthetic, and natural product inspired by small molecules which can be used as probes for developing an understanding of biological phenomena, which include protein-protein interactions and modulation of signal transduction pathways. The Malhotra laboratory employs the use of synthetic medicinal chemistry, molecular modeling, and chemical biology for translational research in drug discovery, development, imaging, and radiation. We are a multi-disciplinary group with expertise in biology, chemistry, and medicine working towards understanding radiation and cancer biology and improving treatment of human disease.

Laboratory News

Stanford-SRI Drug Discovery and Development Program

A new collaborative program between scientists at SRI Biosciences, a division of SRI International, and physician-researchers from Stanford Cancer Institute (SCI) has been started, which will pursue development of novel compounds to treat multiple forms of cancer and other conditions. The program will be co-led by Sanjay V. Malhotra, Ph.D., FRSC, associate professor of Radiation Oncology at Stanford, and Nathan Collins. Together they will coordinate and support a diverse and evolving group of investigators and technical experts to advance promising projects.